Wall Street investment banks brought in a record amount of fees for fundraisings in the first six months of 2020 amid coronavirus, UK prime minister Boris Johnson plans to announce £5bn of infrastructure projects today, and Gilead Sciences has said it will charge governments $2,340 for a 5-day course of its coronavirus treatment, remdesivir. Plus, the FT’s Primrose Riordan explains why investors, economists, and analysts are growing concerned over China’s national security law in Hong Kong. 

See acast.com/privacy for privacy and opt-out information.

View our accessibility guide.

Copyright The Financial Times Limited 2023. All rights reserved.
Reuse this content (opens in new window) CommentsJump to comments section

Follow the topics in this podcast


Comments have not been enabled for this article.